CFTR and cystic fibrosis: Since RFFL knockdown improves ∆F508–CFTR PM stability, RFFL inhibitors also are expected to be CFTR stabilizers, a first-in-class CF drug, which helps maintain functional ∆F508–CFTR at the PM and improves the limited efficacy of the CF drug Orkambi® [71].